A vaccine from Sanofi and GSK is said to produce strong immune responses in a mid-stage study. May 17, 2021 A Phase 3 trial will start in the coming weeks. The drug makers expect their shot will become available in the last three months of this year. IFTTT NYT NYT > Business NYTimes +